Neuractas Therapeutics is a Canadian pharmaceutical company that is developing novel agents for neurological indications. Neuractas has developed neur-04 for epilepsy, this agent is a reformulation of an existing drug that has demonstrated strong clinical anticonvulsant activity in the most difficult-to-treat cases of epilepsy. Often people with epilepsy have to try several different medications before […]
Read More